A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems

References

• Yfantopoulos JN, Chantzaras ADrug policy in GreeceValue Health Reg Issues2018 10.1016/j.vhri.2018.06.006
   PubMedGoogle Scholar
• Wiśniewski M, Religioni U, Merks PCommunity pharmacies in Poland—the journey from a deregulated to a strictly regulated marketInt J Environ Res Public Health2020 10.3390/ijerph17238751
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Regional Office for Europe. The legal and regulatory framework for community pharmacies in the WHO European Region. World Health Organization. Regional Office for Europe. 2019. https://apps.who.int/iris/handle/10665/326394. Accessed 12 Dec 2021.
   Google Scholar
• Martins SF, Van Mil JW, Da Costa FAThe organizational framework of community pharmacies in EuropeInt J Clin Pharm2015 10.1007/s11096-015-0140-1
   PubMed Web of Science ®Google Scholar
• Vogler S. Liberalization in the pharmacy sector. OECD Global Forum on Distribution. 2014. https://jasmin.goeg.at/id/eprint/258. Accessed 12 Dec 2021.
   Google Scholar
• Oleszkiewicz P, Krysinski J, Religioni U, Merks PAccess to medicines via non-pharmacy outlets in European countries—a review of regulations and the influence on the self-medication phenomenonHealthcare2021 10.3390/healthcare9020123
   Web of Science ®Google Scholar
• Vogler S, Arts D, Habl C. Community pharmacy in Europe. Lessons from deregulation–case studies. 2006. https://jasmin.goeg.at/id/eprint/241. Accessed 20 Dec 2021.
   Google Scholar
• Lluch M, Kanavos PImpact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and SpainHealth Policy2010 10.1016/j.healthpol.2009.11.002
   PubMed Web of Science ®Google Scholar
• Vogler S, Habimana K, Arts DDoes deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countriesHealth Policy2014 10.1016/j.healthpol.2014.06.001
   PubMed Web of Science ®Google Scholar
• Moura A, Barros PPEntry and price competition in the over-the-counter drug market after deregulation: evidence from PortugalHealth Econ2020 10.1002/hec.4109
   PubMed Web of Science ®Google Scholar
• Anell ADeregulating the pharmacy market: the case of Iceland and NorwayHealth Policy2005 10.1016/j.healthpol.2005.01.020
   Web of Science ®Google Scholar
• Vogler SMedicine Price surveys, analyses and comparisons: evidence and methodology guidance20181CambridgeAcademic Press
   Google Scholar
• Stargardt T, Schreyögg J, Busse RPricing behaviour of pharmacies after market deregulation for OTC drugs: the case of GermanyHealth Policy2007 10.1016/j.healthpol.2007.04.006
   PubMed Web of Science ®Google Scholar
• Andersson F, Hatziandreu EThe costs and benefits of switching a drug from prescription-only to over-the-counter statusPharmacoEcon1992 10.2165/00019053-199202050-00006
   Google Scholar
• Morgan OW, Griffiths C, Majeed AInterrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoningPLoS Med2007 10.1371/journal.pmed.0040105
   PubMed Web of Science ®Google Scholar
• Morthorst BR, Erlangsen A, Nordentoft M, Hawton K, Hoegberg LCG, Dalhoff KPAvailability of paracetamol sold over the counter in Europe: a descriptive cross-sectional international survey of pack size restrictionBasic Clin Pharmacol Toxicol2018 10.1111/bcpt.12959
   PubMed Web of Science ®Google Scholar
• Hopkins AG, Spiller HA, Kistamgari S, Zhu M, Michaels NL, Funk AR, Smith GASuicide-related over-the-counter analgesic exposures reported to United States poison control centers, 2000–2018Pharmacoepidemiol Drug Saf2020 10.1002/pds.4997
   PubMed Web of Science ®Google Scholar
• Leopold C, Vogler S, Mantel-Teeuwisse AK, de Joncheere K, Leufkens HG, Laing RDifferences in external price referencing in Europe—a descriptive overviewHealth Policy2012 10.1016/j.healthpol.2011.09.008
   PubMed Web of Science ®Google Scholar
• Sandulovici R, Mircioiu C, Rais C, Atkinson JPharmacy practice and education in RomaniaPharmacy2018 10.3390/pharmacy6010005
   Google Scholar
• Gallone EL, Enri LR, Pignata I, Baratta F, Brusa PThe 2017 deregulation of pharmacies in Italy: introducing non-pharmacist ownershipHealth Policy2020 10.1016/j.healthpol.2020.08.013
   PubMed Web of Science ®Google Scholar
• Tamasauskas D, Sakalauskas V, Kriksciuniene D. Evaluation framework of hierarchical clustering methods for binary data. In: 12th International Conference on Hybrid Intelligent Systems (HIS). (2012).
   Google Scholar
• SPF Economie. Médicaments en vente libre ou médicaments OTC (Over The Counter) | SPF Economie. https://economie.fgov.be/fr/themes/ventes/politique-des-prix/prix-reglementes/medicaments-usage-humain/medicaments-originaux/medicaments-en-vente-libre-ou. Accessed 10 Jan 2022.
   Google Scholar
• Oikeusministeriö. Valtioneuvoston asetus lääketaksasta 713/2013 - Ajantasainen lainsäädäntö - Finlex. https://www.finlex.fi/fi/laki/ajantasa/2013/20130713. Accessed 15 May 2022.
   Google Scholar
• Dimova A, Rohova M, Atanasova E, Kawalec P, Czok KDrug policy in BulgariaValue Health Reg Issues2017 10.1016/j.vhri.2017.08.001
   PubMedGoogle Scholar
• Silins J, Szkultecka-Dębek MDrug policy in LatviaValue Health Reg Issues2017 10.1016/j.vhri.2017.08.006
   PubMedGoogle Scholar
• Barbarisi I, Bruno G, Diglio A, Elizalde J, Piccolo CA spatial analysis to evaluate the impact of deregulation policies in the pharmacy sector: evidence from the case of NavarreHealth Policy2019 10.1016/j.healthpol.2019.08.010
   PubMed Web of Science ®Google Scholar
• Journal Officiel du Grand-Duché de Luxembourg. Règlement grand-ducal du 27 mai 1997 relatif à l’octroi des concessions de pharmacie. - Legilux. https://legilux.public.lu/eli/etat/leg/rgd/1997/05/27/n1/jo. Accessed 12 Feb 2022.
   Google Scholar
• Vogler S, Arts D, Sandberger K. Impact of pharmacy deregulation and regulation in European countries. 2012. https://jasmin.goeg.at/id/eprint/227. Accessed 20 Dec 2021.
   Google Scholar
• Government Gazette. ΦΕΚ 1445/Β/23.06.2016 – Ρυθμίσεις επαγγέλματος φαρμακοποιού – Ίδρυση φαρμακείου. https://www.sfee.gr/fek-1445v23-06-2016-rithmisis-epangelmatos-farmakopiou-idrisi-farmakiou/. Accessed 23 Feb 2022.
   Google Scholar
• Bratkowska K, Religioni U, Krysiński J, Merks PQuality of pharmaceutical services in independent pharmacies and pharmacy chains in Poland from the patient perspectivePatient Prefer Adherence2020 10.2147/PPA.S284014
   PubMed Web of Science ®Google Scholar
• Briesacher B, Corey RPatient satisfaction with pharmaceutical services at independent and chain pharmaciesAm J Health Syst Pharm1997 10.1093/ajhp/54.5.531
   PubMed Web of Science ®Google Scholar
• Jacobs S, Hassell K, Ashcroft D, Johnson S, O’Connor EWorkplace stress in community pharmacies in England: associations with individual, organizational and job characteristicsJ Health Serv Res Policy2014 10.1177/1355819613500043
   PubMed Web of Science ®Google Scholar
• Mott DA, Doucette WR, Gaither CA, Pedersen CA, Schommer JCPharmacists’ attitudes toward worklife: results from a national survey of pharmacistsJ Am Pharm Assoc2004 10.1331/154434504323063968
   Google Scholar